当前位置:首页 > 期刊 > 《医药产业资讯》 > 2010年第1期 > 正文
编号:13196804
鼻咽癌放化疗及分子靶向治疗进展(1)
http://www.100md.com 2010年1月5日 《中国医药导报》2010年第1期
     [摘要] 鼻咽癌的有效治疗手段是放疗和以放疗为主的综合治疗,但远处转移及局部复发仍是治疗失败的主要原因。因此,提高局控率、降低远处转移率及提高总体生存率的综合治疗模式成为当前研究的热点,现就单纯放疗、放化疗综合治疗及放疗+分子靶向治疗的临床应用和前景作一综述。

    [关键词] 鼻咽癌;放疗;化疗;分子靶向治疗;进展

    [中图分类号] R739.6 [文献标识码]A [文章编号]1673-7210(2010)01(a)-019-03

    The development of radiotherapy and chemotherapy as well as molecular targeted therapy for nasopharyngeal carcinoma

    GAO Yang, BAO Yongxing

    (The Center of Tumor in the First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China)

    [Abstract] Radiotherapy or combined therapy in which radiotherapy is the main position is the effective therapeutic tool for nasopharyngeal carcinoma, but distant place to transfer and partly relapse are the main causes of treatment failure, so how to boost the local control and prospective efficacy with nasopharyngeal carcinoma has become the study hot spot. This paper aims directly at radiotherapy, radiotherapy and chemotherapy plus molecular targeted therapy for nasopharyngeal carcinoma, and make a summary on their clinical application and prospect. ......
1 2 3下一页

您现在查看是摘要页,全文长 4580 字符